ICARE Social Media Post April 2022

Breast Cancer Mortality & MRI Screening: ATM, CHEK2, and PALB2

A new study suggests that annual breast MRI screening may reduce deaths from breast cancer by half in women with ATM, CHEK2 and PALB2 gene mutations. The data suggests starting with annual breast MRIs between the ages of 30 to 35, and adding annual mammograms starting at age 40. Read the full article to learn more!
https://jamanetwork.com/journals/jamaoncology/article-abstract/2789164
Reference: Lowry, et al. JAMA Oncol. 2022 Feb 17. PMID: 35175286.

Permanent link to this article: https://inheritedcancer.net/post40122/